Madam Speaker, we hear from the Conservative caucus about the costs of pharmacare. The member spoke about how this is needed for an affordability measure, but we have not heard about how national single-payer pharmacare saves money. The Parliamentary Budget Officer tabled a report saying that $1.4 billion would be saved because national single-payer pharmacare gives governments the negotiating and bargaining power to drive down drug costs. Therefore, it is not surprising to see Conservatives oppose it when their friends, the lobbyists, the CEOs and big pharma keep saying the same things that they do.
Can the member speak to how Conservatives are constantly looking out for the corporations at the very top instead of everyday Canadians who are struggling to pay for essential medications?